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Production and characterization of two 
medium-chain-length polydroxyalkanoates 
by engineered strains of Yarrowia lipolytica
Coraline Rigouin1†, Sophie Lajus1†, Connie Ocando2†, Vinciane Borsenberger1, Jean Marc Nicaud3, Alain Marty4, 
Luc Avérous2 and Florence Bordes1* 
Abstract 
Background: The oleaginous yeast Yarrowia lipolytica is an organism of choice for the tailored production of various 
compounds such as biofuels or biopolymers. When properly engineered, it is capable of producing medium-chain-
length polyhydroxyalkanoate (mcl-PHA), a biobased and biodegradable polymer that can be used as bioplastics or 
biopolymers for environmental and biomedical applications.
Results: This study describes the bioproduction and the main properties of two different mcl-PHA polymers. We 
generated by metabolic engineering, strains of Y. lipolytica capable of accumulating more than 25% (g/g) of mcl-
PHA polymers. Depending of the strain genetic background and the culture conditions, we produced (i) a mcl-PHA 
homopolymer of 3-hydroxydodecanoic acids, with a mass-average molar mass  (Mw) of 316,000 g/mol, showing soft 
thermoplastic properties with potential applications in packaging and (ii) a mcl-PHA copolymer made of 3-hydroxy-
octanoic (3HO), decanoic (3HD), dodecanoic (3HDD) and tetradecanoic (3TD) acids with a  Mw of 128,000 g/mol, 
behaving like a thermoplastic elastomer with potential applications in biomedical material.
Conclusion: The ability to engineer Y. lipolytica to produce tailored PHAs together with the range of possible 
applications regarding their biophysical and mechanical properties opens new perspectives in the field of PHA 
bioproduction.
Keywords: Medium-chain-length polyhydroxyalkanoate, Yarrowia lipolytica, Bioproduction, Engineering, Biopolymer 
characterization
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Background
Polyhydroxyalkanoates (PHAs) are a family of microbial, 
biobased and biodegradable polyesters representing an 
attractive ecofriendly alternative to some fossil-based 
polymers. They are biosynthesized by various types of 
microorganisms in conditions of excess of available car-
bon and of a limited supply of one of the nutrients essen-
tial to bacterial cell growth [1]. The biopolymers are 
synthesized by polymerization of 3-hydroxy fatty acids 
(3-OH FA) by a PHA synthase (PhaC), inside the bacte-
rial cell in the form of granules that serve as carbon and 
energy storage compounds [2]. PHA polymers are cat-
egorized into subclasses according to the side chain of 
their monomers: in particular, short-chain-length PHAs 
(scl-PHA with three to five carbon monomers) and the 
medium-chain-length PHAs (mcl-PHA with six to four-
teen carbon monomers). Copolymers of scl- and mcl-
PHA, block copolymers PHA and homopolymers PHA 
are named based on the monomer arrangements in the 
polymer chains [3]. The properties of these biopolymers 
depend on their molar masses and their macromolecu-
lar architectures (the side chains of their monomers), [3, 
4]. For example, the well-studied scl-PHA, P3HB (poly-
3-hydroxybutyrate), has poor mechanical properties. 
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Indeed, the isotactic and linear chains of P3HB result 
in the formation of large spherulites during crystalliza-
tion, which may lead to a highly crystalline (60%) and 
consequently a brittle material. Besides, P3HB presents 
a poor processability with thermal input due to a high 
thermal sensitivity at a temperature higher than the melt-
ing temperature, with strong chains scissions. P3HB and 
PHBV (poly(3-hydroxybutyrate-co-3-hydroxyvalerate)) 
with a low HV content have not been largely utilized in 
biomedical areas due to the stiff and brittle nature. On 
the other hand, mcl-PHA properties ranges from rub-
ber to tacky polymers with higher thermal resistance 
[5, 6]. Diverse products can thus be obtained from PHA 
including bioplastics, chemicals and feed supplements 
[7]. Besides, different applications in medical and phar-
maceutical industries can be considered [8, 9]. The main 
drawback to PHA usage is its high cost of production 
compared to conventional fossil-based polymers. None-
theless, advances in PHA research have shown tremen-
dous progresses in (i) finding alternative carbon sources 
for PHA production (ii) controlling PHA processing dur-
ing production, and (iii) controlling PHA composition 
and molar mass [10–12].
Medium-chain-length PHAs are made up of mono-
mer units with 6–14 carbon atoms and were first iden-
tified in Pseudomonas putida GPo1 [13]. mcl-PHA are 
interesting as they can bear different functional groups 
in the side chains that can modify the physico-chemical 
and physical properties, offering a wide range of appli-
cations [3]. Depending of the monomer composition, 
mcl-PHA have been demonstrated to have the elasto-
meric properties required for specific applications such 
as packaging materials or biomedical applications [3, 
14]. Nevertheless, inconsistencies on their molar masses 
and their structures lead to variations of their thermo-
mechanical properties, which are a strong drawback for 
their uses. Some organisms are naturally capable of syn-
thesizing mcl-PHA and have been engineered in order to 
enhance polymer production or to produce mcl-PHA of 
interest [15–17]. Non-natural mcl-PHA producers have 
also been engineered such as yeast [18–21], bacteria [16, 
22–24], and plants [23, 25].
Yarrowia lipolytica is a GRAS organism (Generally 
Regarded As Safe) with large potentials in industrial bio-
technology [26]. This yeast is naturally capable of produc-
ing and accumulating large amount of lipids (more than 
50% of its dry weight in large-scale fermentations [27]). In 
regard to such potential, this yeast is becoming an organ-
ism of choice for the production of many compounds 
such as lipids [27, 28], proteins [29] and biopolymers [18]. 
It is naturally capable of growing on different substrates 
(sugars, oils, alkane, glycerol) and has been recently engi-
neered to accept inexpensive carbon sources [30, 31]. Y. 
lipolytica was used to produce both PHA copolymer and 
homopolymer with an external fatty acid (FA) supply and 
the expression of the PhaC synthase from Pseudomonas 
aeruginosa [18, 19]. Haddouche et al. [19] redirected the 
FA flux toward β-oxidation by deleting the neutral lipid 
synthesis pathway and by overexpressing the 2-enoyl-
CoA hydratase domain of the MFE protein to enhance 
the synthesis of the 3-OH FA precursor. This led to an 
accumulation of PHA up to 7% of cell dry weight (CDW). 
However, the properties of the produced PHA were not 
investigated, likely because of its low accumulation level.
The production of tailor-made mcl-PHAs using diverse 
FA precursors could lead to different polymer properties 
for new materials. When using an heterologous organ-
ism, it is important to evaluate the resulting polymer 
with respect to the accumulation capacity, the yield, the 
polymer constituents, and the material properties. In this 
paper, we describe the production and the characteriza-
tion of two mcl-PHA in Y. lipolytica, an homopolymer 
and a copolymer, highlighting the capacity of the engi-
neered strain to accumulate high amount of polymer and 
giving evidence for the bioproduction of two different 
materials with distinct properties.
Methods
Strains construction
PhaC variants strains: the wild type version of PhaC 
was cloned on the JMP62 pTEF_URA3ex plasmid [32]. 
Variants of the PhaC synthase were then generated by 
directed mutagenesis using the QuikChange II Site-
Directed Mutagenesis Kit (Agilent), and the list of prim-
ers listed in Additional file  1: Table  S4. After directed 
mutagenesis, the gene sequences were checked by 
Sanger sequencing services from GATC Biotech (Con-
stance, Germany). After construction, all the plasmids 
were linearized and used to transform Y. lipolytica strain 
JMY_1877 [33]. The yeast cells were made competent and 
transformed using Frozen-EZ Transformation kit (Zymo 
Research, Irvine, CA, USA). Yeast transformants were 
selected by auxotrophy on the adequate minimal medium 
and the presence of the genes of interest was checked 
by PCR. All the constructed strains used are described 
(Additional file 1: Table S1). ThYl_1166 was constructed 
by transformation of the strain JMY2333, a derivative of 
the strain JMY1915 [19], with the plasmids JMP62 pTEF-
PhaC_E130D S325T S477R-URA3ex and the plasmid 
JMP62 pTEF-CpPCT-LEU2ex. ThYl_657 was obtained 
by transformation of a the strain JMY2475 with the plas-
mid JMP62 pTEF-PhaC_E130D S325T S477R-URA3ex 
and the strain ThYl_1024 by transformation of the strain 
JMY2475 with the plasmid JMP62 4UAS-tef MfeC-
LEU2ex [34] and the plasmid JMP62 pTEF-PhaC_E130D 
S325T S477R-URA3ex.
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Cultures for PHA production
Pre-cultures were started from fresh colonies in 20 mL 
of the rich medium YPD (yeast extract 10  g/L, bacto-
peptone 10 g/L, glucose 10 g/L). Minimal medium YNB 
(glucose 40  g/L, YNB w/o AA 1.7  g/L,  NH4Cl 5  g/L, 
phosphate buffer pH 6.8 50 mM) was used to grow cells 
for PHA production. Solutions of fatty acid methyl 
esters [methyl myristate (mC14) and methyl laurate 
(mC12)] were prepared at 20% (v/v) in  H2O and Ter-
gitol or tween. After 24  h and 48  h of culture, 2.5  g/L 
mC14 or mC12 was added. As exogenous medium 
chain fatty acids may be toxic to the cells at high con-
centration, mC14 was added sequentially and during 
the exponential growth phase rather than in one time 
at the beginning. After 5 days of culture, cells were har-
vested by centrifugation (500×g 10 min), washed once 
with 50% isopropanol (to remove excess fatty acids 
from the medium) and twice with  H2O and stored 
at − 80  °C. Upon thawing, cells were resuspended in 
100  mM Tris–HCl buffer at pH 8 with 0.5  mg/mL of 
zymolyase and lysed with a 28  °C incubation for 18  h 
with shaking. Cells were then freeze-dried until PHA 
extraction.
PHA extraction
Polymer was extracted with chloroform from the dried 
cells using a Soxhlet apparatus. Typically, 50 mL of sol-
vent were used to extract polymer from 1.5 g of dried 
cells and the filling and emptying cycles of the cham-
ber were allowed to process 10 times before collection 
of the solvent containing the extracted materials. PHA 
in chloroform was then filtered using a 40 mL Graces’ 
 Reveleris® cartridge and precipitated by addition of 1 
volume of ethanol for 2 volumes of chloroform, fol-
lowed by cooling at − 20  °C. After centrifugation, the 
supernatant was discarded, the PHA was dried on air 
and then used for further analysis.
NMR
Polymer quantities were determined by NMR on a 
Bruker Avance II 500 spectrometer. The cells extracts 
were thoroughly dried, prior to being diluted in  CDCl3 
containing 1% TMS (internal standard) and transferred 
to 5  mm NMR tubes. NMR spectra were recorded at 
298  K. Each NMR spectrum was acquired using an 
excitation flip angle of 30° at a radiofrequency field of 
29.7 kHz, a relaxation delay of 10 s and 2 dummy scans. 
For each experiment, 16 scans were performed with 
a repetition delay of 6.5  s. PHA concentrations were 
determined by integration of the two specific AB dou-
ble doublets at 2.55 ppm.
Transmethylation and GC/MS analysis
PHA monomer composition was analyzed by trans-
methylation of the polymer in hot acid methanol [35]. 
Briefly, 2  mL of a solution of methanol (with C17 FA 
prepared at 0.2  mg/mL as standard) with 2.5% sulfu-
ric acid was added to the dried sample in addition to 
1  mL of Toluene. Samples were heated at 80  °C for 
3 h. Once the samples were cooled down, biphasic liq-
uid extraction took place using 1.5  mL of 0.5  M NaCl 
and 1.5  mL hexane (containing mC20 FA at 0.1  mg/
mL as internal standard). Analyses were performed 
on the organic phase with a gas chromatography cou-
pled with mass spectrometry (GC–MS) TRACE™ 1310 
equipped with the TRACE™ TR-5 column (Thermo-
scientific). Standards of 3-OH fatty acids methyl esters 
were used to determine retention time and for relative 
quantification.
Size exclusion chromatography (SEC)
The number average molar mass (Mn), the mass aver-
age molar mass (Mw) and the dispersity (Đ) of the PHA 
samples were determined by SEC, using a Malvern 
Instrument apparatus (Viscotek RImax). This device was 
equipped with a guard column 10 mm (8 μm) and three 
300  mm columns (50, 150 and 500  Å). Refractive index 
(RI) and ultra-violet (UV) detectors were used. Tetrahy-
drofuran (THF) was used as the eluent at a flow rate of 
1 mL/min. The apparatus was calibrated with linear poly-
styrene standard from 162 to 20,000 g/mol.
Elemental analysis
Elementary analyses were performed on a ThermoFisher 
Scientific “Flash 2000” (US) device (absolute precision of 
0.3%) with 1 mg sample burned up to 950 °C.
Thermogravimetric analysis (TGA)
Thermal degradations were studied by TGA. Measure-
ments were conducted under nitrogen atmosphere (flow 
rate of 25 mL/min) using a Hi-Res TGA Q5000 appara-
tus from TA Instruments. Samples (1–3 mg) were heated 
from room temperature up to 700  °C at a rate of 20  °C/
min.
Differential scanning calorimetry (DSC)
Crystallization behavior of both PHAs was studied on a 
DSC Q 200 (TA Instruments). Samples of around 3  mg 
were heated from 25 to 180 °C at 10 °C/min under nitro-
gen flow (50 mL/min). This first scan was conducted in 
order to erase the thermal history of the bulk polymer. 
In ramp 2, the sample was cooled at 5 °C/min to − 70 °C 
and kept isothermal for 3 min. In ramp 3, the sample was 
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once again heated at 10  °C/min to 180  °C. Ramp 3 was 
used for determination the glass transition temperature 
 (Tg), melting temperature  (Tm) and heat of fusion (ΔHm).
Uniaxial tensile tests
After a thermal treatment at 37  °C for 5  days (body 
temperature) of thin films (10 × 5 × 0.2  mm3) prepared 
by solvent casting, tensile tests were performed with a 
Discovery HR hybrid rheometer (TA instruments) at 
a crosshead displacement rate of 10  mm/min, at room 
temperature.
Results and discussion
Polymer accumulation depending on PhaC synthase 
variant expressed by the yeast
Recent studies have demonstrated that some specific 
mutations in PhaC can enhance, alone or in combina-
tion, PHA polymer production and composition when 
expressed in bacteria [36, 37]. Consequently, we inves-
tigated the capacity of different PhaC synthase variants 
(Additional file  1: Table  S1) to produce and accumulate 
PHA copolymer in Y. lipolytica. The strain JMY_1877 
[19] was used as a chassis strain to express the PhaC vari-
ants under the strong constitutive promoter pTEF and 
to produce PHA copolymer. PhaC was targeted to the 
peroxisome as this compartment is the site of fatty acid 
degradation by the β-oxidation pathway and therefore 
the site where 3-OH FAs, the substrates of PhaC, are syn-
thesized as intermediates of the β-oxidation pathway. In 
this strain, lipid accumulation is abolished by the deletion 
of acyl-transferases in order to reduce fatty acids storage 
and improve their availability for PHA production.
The strains expressing the different PhaC variants 
were grown for PHA production as described in “Meth-
ods” section with methyl myristate (mC14) as precur-
sor. Cells were then harvested, the polymer extracted 
and the polymer accumulation and composition were 
measured (Additional file  1: Table  S2). The first set 
of strains expressing PHA variants that we generated 
(ThYl_1475, 1479, 1480, 1481, 1485, 1487 and 1494) 
accumulated higher or equivalent levels of polymer than 
the ThYl_1475 strain expressing the wild-type PhaC. The 
most interesting variant, ThYl_1494, combined the four 
mutations E130D S325T S477R Q481M and led to 27% 
accumulation of polymer. The second set of variants gen-
erated (corresponding to the strains ThYl_1491, 1496 and 
1498) combined the quadruple mutations and the muta-
tions S482G, L484V and A547V respectively. No syn-
ergistic effect on polymer accumulation was observed: 
the strain ThYl_1491 showed similar performance than 
ThYl_1494 and the strains ThYl_1496 and ThYl_1498 lost 
their ability to improve polymer accumulation. Finally, we 
chose to use the quadruple variant PhaC E130D S325T 
S477R Q481M for downstream experiments.
NMR analysis and transmethylation followed by 
GC–MS analysis gave evidence for the production of a 
PHA composed of 3-OH FAs of different chain lengths, 
except for the strain ThYl_1496 in which no production 
occurred (Additional file  1: Table  S2). In term of fatty 
acid composition, no major difference was observed 
among the PHA produced by the different strains tested. 
The composition is as follows: 26 to 30% of 3HO; 32 to 
36% of 3HD; 25 to 29% of 3HDD and 9 to 13% of 3HTD.
mcl‑PHA copolymer production
Having identified a PhaC variant with a high capacity to 
accumulate PHA polymers in Y. lipolytica, we decided to 
investigate the physical properties of two polymers pro-
duced by this yeast: a copolymer and an homopolymer.
For the copolymer production, we used the strain 
ThYl_1166 (Additional file 1: Table S1). In this strain the 
MFE protein [containing the two hydrogenase domains 
(domains A and B) and the single hydratase domain 
(domain C)] is expressed under pPOX2, the strong fatty 
acid inducible promoter, to force fatty acid degrada-
tion. Consequently, this strain generates high amounts 
of 3-OH FAs, the substrates of PhaC synthase. This host 
successfully expressed the variant PhaC_E130D S325T 
S477R Q481M. ThYl_1166 was grown as described in 
“Methods” section with mC14 FA. After 5  days, when 
the OD reached 25 and the glucose was completely con-
sumed, we stopped the cultures. After polymer extrac-
tion, NMR and transmethylation analysis revealed that 
in these conditions, the strain ThYl_1166 accumulated 
27% (g/g of DCW) of a mcl-PHA polymer composed 
of 29% of 3HO, 35% of 3HD, 26% of 3HDD and 10% of 
3HTD (Table  1 and Additional file  1: Figure S1). These 
results are quite closed to the one observed for the PHA 
Table 1 PHA accumulations and compositions
nd not detectable
Strain Substrate PHA accumulation % 
(g/g)
Fraction of 3OH FA (mmol)
3HO 3HD 3HDD 3HTD
ThYl_1166 mC14 (5 g/L) 27% 29% 35% 26% 10%
ThYl_1024 mC12 (5 g/L) 28% nd nd > 99% nd
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produced by strain ThYl_1491 suggesting that the differ-
ence in genetic pattern between ThYl_1166 (Q4, Δmfe1, 
pPOX-MFEABC, pTEF-PhaC_E130D S325T S477R 
Q481M-URA3ex, pTEF-CpPCT-Leu2ex) and ThYl_1491 
(Q4, pTEF-PhaC_E130D S325T S477R Q481M S482G 
L484V-URA3ex, Leu2ex) did not affect PHA composi-
tion and accumulation.
mcl‑PHA homopolymer
For the homopolymer production, only the C domain 
of the MFE protein (MFEC), encoding the 2-enoyl-CoA 
hydratase, essential to generate exclusively the 3-OH FA, 
substrates of PHA synthase was re-introduced into a Q4 
Δmfe strain expressing the quadruple variant of the PhaC 
synthase (E130D, S325T, S477R and Q481M). The two 
dehydrogenase domains of the MFE protein were not re-
introduced in order to avoid further degradation of the 
3-OH FAs. We obtained the strain ThYl_657 (Additional 
file 1: Table S1). To optimize the production, we also gen-
erated a strain overexpressing MFEC by adding in the 
genome, a second copy of the mfeC gene under the con-
trol of the strong promoter 4UASTEF. We obtained the 
strain ThYl_1024 (Additional file 1: Table S1). To evalu-
ate the best substrate for homopolymer production, both 
strains ThYl_1024 and ThYl_657 were first grown in min-
imal medium with either methyl laurate (mC12) or mC14 
as fatty acid precursors. After 5 days of culture, polymers 
were extracted and the polymers accumulations were 
estimated by NMR. The best accumulation level was 
obtained with the strain ThYl_1024 grown with mC12 
with 15% (g/g) vs. less than 9% (g/g) for the others condi-
tions (Additional file 1: Table S3). This result highlighted 
the interest to have a double copy of the mfeC gene to 
maximize the pool of the 3-OH FA precursor. Therefore, 
this combination of strain and fatty acid was used for a 
larger scale production.
ThYl_1024 was grown in 10 L of YNB supplemented 
with mC12 FA. After 5 days of culture and the addition 
of twice 2.5 g/L of mC12 the polymer was extracted and 
analyzed. In these conditions, ThYl_1024 strain accu-
mulated 28% of PHA. NMR studies gave evidence of a 
homopolyester and GC analysis confirmed the produc-
tion of a polymer composed of 3HDD chains (Additional 
file 1: Figure S2 and Table 1).
This study clearly validates the optimization of the bio-
production of two types of polymers: by testing PhaC 
variants, we identified a PhaC enzyme variant (with 
E130D S325T S477R and Q481M mutations) with high 
performance in polymer accumulation in Y. lipolytica. 
We showed that the four mutations introduced within 
PhaC led to a fourfold improvement of polymer accu-
mulation in the yeast with no impact on cell growth and 
polymer composition. It is quite surprising that the side 
chains of the 3-OH-FAs composing the PHA produced 
by the PhaC variants were not smaller than the ones 
composing the polymer produced by the wild-type PhaC. 
Indeed, some of the mutations tested were described to 
preferentially accommodate 3-hydroxy-butyric acid sub-
strate (with four carbon atoms only) [37, 38]. Our results 
suggest that those mutations either improved the PhaC 
efficiency in the yeast with no change in substrate spec-
ificity or that in Y. lipolytica, small 3-OH FAs are more 
efficiently used by the MFE enzyme than by the PhaC 
enzyme. Then, we optimized the production of mcl-PHA 
homopolymer: the addition of a second copy of the 2 
enoyl-CoA hydratase gene in Y. lipolytica genome, placed 
under a strong promoter, led to a 1.7-fold increase in 
polymer accumulation. Overall, the accumulation of both 
homopolymer and copolymer reached 28% (g/g) of CDW, 
corresponding to approximatively 2.9 g/L of culture. If we 
compare this result to the bioproduction of mcl-PHA in 
other heterologous organisms, our yeast system is more 
performant. In engineered Saccharomyces cerevisiae, 
mcl-PHA accumulation did not exceed 7% (g/g) of CDW 
[39], in Y. lipolytica, mcl-PHA was produced only at 1 g/L 
of culture [18] and in the bacteria Escherichia coli, mcl-
PHA production was estimated to be 6% (g/g) of CDW 
[24].
In our strategy, we took advantage of the synthesis of 
3-OH FAs, as intermediates of the β-oxidation pathway, 
to produce PHA. Contrary to prokaryotic host in which 
mcl-PHA synthesis occurs in the cytoplasm, in yeast, the 
PHA synthesis is confined in the peroxisome where the 
β-oxidation takes place. This confinement presents a dou-
ble benefit: it allows the concentration of the substrate 
(3-OH FA) and the enzyme (PHA synthase), enhanc-
ing the production of high molecular weight polymers. 
In addition, it allows a tight control of the monomeric 
composition. Indeed, the 3-OH FAs coming from the 
de novo fatty acid biosynthesis are located in the cyto-
plasm and cannot be used as substrate for polymer syn-
thesis. Hence, the key interest of our strategy is to take 
advantage Y. lipolytica capacity to efficiently incorporate, 
activate FA and transport them to the peroxisome where 
they are degraded or incorporated into PHA.
Polymer characterizations
The high accumulation rate of both PHA polymers in Y. 
lipolytica allowed us to purify the polymers and to carry 
out the analysis of their physical, thermal and mechanical 
properties.
Molar masses and purity
The number-average molar mass  (Mn), the mass-average 
molar mass  (Mw), and the dispersity (Ð) of the PHA sam-
ples were determined by size exclusion chromatography 
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(SEC) using THF as eluent. The PHA copolymer showed 
values of  Mn and  Mw around 78,500 and 127,700  g/
mol respectively with a dispersity of 1.6 while the PHA 
homopolymer showed higher  Mn and  Mw with values 
around 156,400 and 316,400  g/mol, respectively, and 
dispersity of 2 (Table 2). These results indicate a narrow 
molar mass distribution and  Mn values similar to com-
mercial P3HB from e.g. Biocycle©, produced by micro-
bial fermentation  (Mn = 180,000  g/mol and Ð = 2.3, 
determined by SEC) [40]. Elemental CHN analysis was 
carried out and showed that the amount of nitrogen, a 
good indicator of protein content and consequently of 
purification state, was below 0.5%. This indicates that the 
amount of residual impurities in the polymers is negligi-
ble (Table 2). It is a key point since these impurities are 
well-known to catalyze the degradation of these biopoly-
mers under thermal input.
Thermal properties of the mcl‑PHAs
Table  3 summarizes the thermal properties of PHAs 
determined from DSC analyses. As can be seen, the two 
PHAs presented significant differences in their ther-
mal behaviors. For instance, the lower melting enthalpy 
(ΔHm) and melting point  (Tm), measured for the copol-
ymer indicated a more amorphous behavior than the 
homopolymer. The glass transition and melting tem-
perature  (Tg and  Tm) of the PHA polymers were low and 
indicative of a flexible polymer at ambient temperature. 
These values are similar with the − 60  °C glass transi-
tion temperature and the 60  °C melting temperature of 
the polycaprolactone a widely used polymer in the field 
of biomedical application. In addition, although the crys-
tallinity index of these materials could not be calculated 
since the enthalpies of the perfect PHA crystals are not 
available for these particular PHAs; a rough estimation 
of this value was obtained. We used the endothermic 
melting enthalpy determined by the second heating 
(ΔHm) of each PHA and the melting enthalpy (ΔHmo) of 
100% crystalline P3HB according to equation  Xc = ΔHm/
ΔHmo, assuming 146  J/g as the melting enthalpy of 100% 
crystalline P3HB as cited in literature [40]. From these 
results, it is possible to point out that the degree of crys-
tallinity and melting temperature of both PHAs were sig-
nificantly lower than the commercial P3HB that are 60% 
and 175  °C, respectively. Additionally, both PHAs pre-
sented two melting peaks, possibly due to different crys-
talline domains.
Thermogravimetric analysis of the mcl‑PHAs
Thermogravimetric analysis (TGA) was used to evalu-
ate the thermal stability of the two PHA (Table 4). Since 
some PHAs present a high thermal sensitivity such as the 
P3HB, with chains scissions and polymers degradations, 
this evaluation is major. The results showed that the poly-
mers were thermally stable up to at least 200 °C and both 
displayed a single degradation step at a maximum degra-
dation temperature of 225 and 253 °C for the PHA copol-
ymer and the PHA homopolymer, respectively. Published 
studies reported the highest temperature of maximum 
degradation rate for a commercial P3HB homopolymer 
at around 288 °C [40].
Table 2 Results of the chains characterizations by SEC and elementary analysis of the PHAs
Sample SEC Elementary analysis
Mn (g/mol) Mw (g/mol) Ð C (%) H (%) N (%)
PHA copolymer 78,500 127,700 1.6 69.3 ± 0.1 10.4 ± 0.1 0.4 ± 0.03
PHA homopolymer 156,400 316,400 2.0 72.6 ± 0.2 10.9 ± 0.03 0
Table 3 Main thermal properties of the PHAs
Sample DSC cooling DSC 2nd heating
Tc1 (°C) Tc2 (°C) Tc3 (°C) ΔHc (J/g) Tm1 (°C) Tm2 (°C) ΔHm (J/g) Χc (%) Tg (°C)
PHA copolymer − 9 n.o n.o 8.3 19 57 7.7 5.3 − 39
PHA homopolymer 40 5.5 n.o 45.5 45 72 43.9 30.1 n.o
Table 4 Thermal degradation temperature at  2 wt% loss 
 (Td,2%) and  maximum degradation  (Td,max) temperature 
of the PHAs
Sample TGA (under nitrogen)
Td,2% (°C) Td,max (°C)
PHA copolymer 204 225
PHA homopolymer 226 253
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Mechanical properties of the mcl‑PHAs
To evaluate the mechanical properties of these two poly-
mers, uniaxial tensile test was performed (Table 5, Addi-
tional file 1: Figure S3). The result showed that the PHA 
copolymer displayed an elastomeric behavior indicated 
by a low yield stress, low Young’s modulus and high elon-
gation at break values, in agreement with its low melting 
temperature and low crystallinity. In contrast, the PHA 
homopolymer showed thermoplastic elastomer prop-
erties with high tensile strength, high Young’s modulus 
and elongation at break values corresponding to a semi-
ductile behavior. For comparison, a brittle thermoplastic 
behavior has been reported for the commercial P3HB 
from Biocycle© with maximum elongation at break 
around 4 and 2%, tensile strength around 25 and 40 MPa 
and flexural modulus of around 3800 and 2200 MPa. The 
differences observed in the mechanical behavior between 
the PHAs and the commercial P3HB from Biocycle© 
agree with their thermal properties.
Both polymers displayed interesting properties: the 
PHA copolymer is an elastomeric material with a low 
yield stress (4.83  MPa) and a high elongation at break 
(755%) due to its low melting temperature (two endo-
thermic peaks at around 19 and 57  °C) and low crystal-
linity (5%). In contrast, the homopolymer has high tensile 
strength (11.45 MPa) and elongation at break values cor-
responding to a semi-ductile behavior (347%) due to its 
low melting temperature (two endothermic peaks at 
around 45 and 71 °C) and higher crystallinity (30%). Both 
polymers present lower crystallinity and higher elasto-
meric properties than P3HB which opens new perspec-
tives of application for PHA.
To summarize the PHA synthesized are amorphous 
polymers with soft and elastomeric behaviors. Such 
properties are generally found for medium-chain-
length PHAs. It is delicate to compare polymers that 
do not display equivalent molar masses and that have 
not been produced in the same conditions. However, 
we try to briefly confront our biosynthesized PHA to 
bacterial mcl-PHA previously characterized in the lit-
erature. For instance, the  Tm and  Tg values measured 
for our polymers are equivalent and consistent to the 
values for mcl-PHA produced by P. putida (around 
60  °C and − 40  °C, respectively) [41–43]. A key-point 
in this comparison is the static mechanical behavior of 
our copolymer and, more particularly the elongation at 
break, higher than 750%. This is one of the highest val-
ues reported in the literature for more or less equiva-
lent architectures. Such a behavior can impact directly 
on potential application areas.
These highly promising biosynthesized materials can 
find applications in distinct fields. The PHA homopoly-
mer behaves like a soft thermoplastic with a high elon-
gation and a low modulus such as e.g. some low-density 
polyethylene. Applications can be found for instance on 
biomedical areas or packaging where the biodegrada-
tion is a clear advantage to manage the end-of-life of the 
corresponding materials. PHA copolymer presents the 
typical mechanical behavior of a thermoplastic elastomer 
(TPE) such as some thermoplastic polyurethane (TPU), 
with uses in biomedical application, shoes, injected rub-
ber gasket, or some seals. However, future studies regard-
ing the mechanical behavior in static or dynamic tests 
need to be undertaken in connection with these potential 
functions. In general, the properties of these elastomeric 
and flexible polymers seem to be adequate for potential 
biomedical high added values purposes for soft tissues, 
such as heart valves, cardiac patches and other vascular 
applications, skin tissue engineering, wound healing and 
controlled drug release or delivery [14]. However, biore-
sorbability in contact with living tissues, biocompatibility 
with in vivo tests and toxicity evaluation have first to be 
carried out.
Future optimization and challenges
The high price of PHA polymer stands as a major draw-
back for its industrialization. This is due to the use of 
expensive purified substrate such as glucose and the cost 
of downstream processes such as extraction and purifi-
cation. To minimize the overall cost of production, it 
would be of interest to take advantage of the ability of Y. 
lipolytica to grow on cheaper substrates such as glycerol. 
Recently, a lot of efforts have been deployed to engineer 
this yeast to grow on biomass-derived substrates [30, 
31]. In addition, optimization of PHA extraction from 
eukaryotic microorganism will have to be investigated. 
In the case of oleaginous organism, recent advances have 
been made to facilitate the process of lipid extraction and 
could be extended to PHA extraction [44, 45].
Table 5 Mechanical properties of PHAs under uniaxial tensile tests at room temperature
Yield stress (MPa) Young’s modulus (MPa) Elongation 
at break 
(%)
PHA copolymer 4.83 ± 0.65 0.019 ± 0.001 755 ± 151
PHA homopolymer 11.45 ± 2.02 0.410 ± 0.080 347 ± 51
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Conclusion
This study presents the optimization of the bioproduc-
tion of mcl-PHA polymers. We showed that metabolic 
engineering of the yeast Y. lipolytica lead to the produc-
tion of two types of mcl-PHA in a heterologous microor-
ganism at levels never reached before. This allowed us to 
fully investigate the biophysical properties of these poly-
mers and to extrapolate on their potential applications. 
This work clearly describes a successful pluridisciplinary 
approach that opens interesting opportunities for pro-
ducing custom made polymers and highlights the power 
of engineering to generate materials meeting the needs of 
society for a more sustainable future.
Additional file
Additional file 1: Table S1. Strains used in this study. pTEF-PhaC: PhaC 
synthase from Pseudomonas aeruginosa targeted to peroxisome and 
expressed under the promoter pTEF; wt: wild type; pPOX2-MFE: MFE 
enzyme from Y. lipolytica expressed under the promoter pPOX2. MFEABC, 
the whole protein with its three catalytic domains is expressed; MFEC: only 
the domain C (encoding the 2 enoyl hydratase) is expressed. Table S2. 
polymer accumulation and composition in Y. lipolytica strains expressing 
different variants of phaC synthase. Table S3. homopolymer accumula-
tion in Y. lipolytica strains expressing the MFEC domain and grown with 
different source of fatty acids as substrate. Table S4. Sequence of the 
primers used in directed site mutagenesis on PhaC. Figure S1. 1H NMR 
spectrum in  CDCl3 with 1% TMS of the cellular extracts of strain ThYl 1166, 
grown in YNB supplemented with mC14 showing almost exclusively 
signals belonging to a mcl-PHA, and traces of free FA. Figure S2. 1H NMR 
spectrum in  CDCl3 with 1% TMS of the cellular extracts of strain ThYl 1024, 
grown in YNB supplemented with C12 showing almost exclusively signals 
belonging to a homopolymer of 3HDD and traces of free FA. Figure S3. 
Stress-strain curves of synthesized PHAs stored at 37 °C during 5 days.
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